BR9707918A - Análogos de oligonucleotídeos - Google Patents

Análogos de oligonucleotídeos

Info

Publication number
BR9707918A
BR9707918A BR9707918A BR9707918A BR9707918A BR 9707918 A BR9707918 A BR 9707918A BR 9707918 A BR9707918 A BR 9707918A BR 9707918 A BR9707918 A BR 9707918A BR 9707918 A BR9707918 A BR 9707918A
Authority
BR
Brazil
Prior art keywords
attached
group
unsubstituted
cycloalkyl
alkenyl
Prior art date
Application number
BR9707918A
Other languages
English (en)
Inventor
Anthony David Baxter
Stephen Paul Collingwood
Mark Edward Douglas
Roger John Taylor
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9707918A publication Critical patent/BR9707918A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9707918A 1996-03-05 1997-02-24 Análogos de oligonucleotídeos BR9707918A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9604669.3A GB9604669D0 (en) 1996-03-05 1996-03-05 Chemical compounds
PCT/GB1997/000499 WO1997032887A1 (en) 1996-03-05 1997-02-24 Oligonucleotide analogues

Publications (1)

Publication Number Publication Date
BR9707918A true BR9707918A (pt) 1999-07-27

Family

ID=10789879

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707918A BR9707918A (pt) 1996-03-05 1997-02-24 Análogos de oligonucleotídeos

Country Status (12)

Country Link
US (1) US6562960B1 (pt)
EP (1) EP0885237B1 (pt)
JP (1) JP2000506849A (pt)
CN (1) CN1212701A (pt)
AT (1) ATE249475T1 (pt)
AU (1) AU1886797A (pt)
BR (1) BR9707918A (pt)
CA (1) CA2247480A1 (pt)
DE (1) DE69724768T2 (pt)
GB (1) GB9604669D0 (pt)
WO (1) WO1997032887A1 (pt)
ZA (1) ZA971849B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639061B1 (en) 1999-07-07 2003-10-28 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate oligomers and related compounds
US6414135B1 (en) 1999-07-07 2002-07-02 Isis Pharmaceuticals, Inc. C3′-methylene hydrogen phosphonate monomers and related compounds
WO2003052133A2 (en) * 2001-12-18 2003-06-26 Human Genetic Signatures Pty Ltd Oligonucleotide analogues comprising intercalator pseudonucleotides
FR2858976B1 (fr) * 2003-08-22 2006-02-10 Isochem Sa Procede d'obtention de n-carboxyanhydrides d'alpha-aminoacides a protection urethane
JP5572090B2 (ja) * 2007-08-15 2014-08-13 アイシス ファーマシューティカルズ, インコーポレーテッド テトラヒドロピラン核酸類似体
CA2744987C (en) 2008-12-02 2018-01-16 Chiralgen, Ltd. Method for the synthesis of phosphorus atom modified nucleic acids
CA2767253A1 (en) 2009-07-06 2011-01-13 Ontorii, Inc. Novel nucleic acid prodrugs and methods of use thereof
EP2620428B1 (en) 2010-09-24 2019-05-22 Wave Life Sciences Ltd. Asymmetric auxiliary group
EP3248982A1 (en) 2011-07-19 2017-11-29 Wave Life Sciences Ltd. Thiosulfonate reagents for the synthesis of functionalized nucleic acids
EP4219516A3 (en) 2012-07-13 2024-01-10 Wave Life Sciences Ltd. Chiral control
SG11201500239VA (en) 2012-07-13 2015-03-30 Wave Life Sciences Japan Asymmetric auxiliary group
WO2014010718A1 (ja) 2012-07-13 2014-01-16 株式会社新日本科学 キラル核酸アジュバント
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
US10144933B2 (en) 2014-01-15 2018-12-04 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
WO2015108046A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
RU2016133035A (ru) 2014-01-16 2018-02-21 Уэйв Лайф Сайенсес Лтд. Хиральный дизайн

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4507433A (en) * 1983-10-07 1985-03-26 The Johns Hopkins University Preparation of oligodeoxyribonucleoside alkyl or arylphosphonates
US4806463A (en) 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
EP0266099A3 (en) 1986-10-28 1990-09-19 The Johns Hopkins University Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids
GB8721442D0 (en) 1987-09-11 1987-10-21 Ciba Geigy Ag Process
JPH04501052A (ja) 1988-02-26 1992-02-27 ザ・ウスター・フアウンデーシヨン・フオー・バイオメデイカル・リサーチ 外来性オリゴヌクレオチドによるhtlv―3の抑制
AU658562B2 (en) 1989-10-24 1995-04-27 Isis Pharmaceuticals, Inc. 2' modified oligonucleotides
US5378825A (en) 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5610289A (en) * 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US6033909A (en) * 1992-01-22 2000-03-07 Hoechst Aktiengesellschaft Oligonucleotide analogs, their preparation and use
US5681747A (en) 1992-03-16 1997-10-28 Isis Pharmaceuticals, Inc. Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
US5625050A (en) 1994-03-31 1997-04-29 Amgen Inc. Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
US5563255A (en) * 1994-05-31 1996-10-08 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
GB9417746D0 (en) 1994-09-03 1994-10-19 Ciba Geigy Ag Chemical compounds

Also Published As

Publication number Publication date
DE69724768T2 (de) 2004-08-05
ATE249475T1 (de) 2003-09-15
GB9604669D0 (en) 1996-05-01
WO1997032887A1 (en) 1997-09-12
EP0885237A1 (en) 1998-12-23
DE69724768D1 (de) 2003-10-16
AU1886797A (en) 1997-09-22
US6562960B1 (en) 2003-05-13
JP2000506849A (ja) 2000-06-06
CA2247480A1 (en) 1997-09-12
CN1212701A (zh) 1999-03-31
EP0885237B1 (en) 2003-09-10
ZA971849B (en) 1997-09-05

Similar Documents

Publication Publication Date Title
BR9707918A (pt) Análogos de oligonucleotídeos
ATE124037T1 (de) Pleuromutiline.
HUP9701169A2 (hu) Cikloalkano-piridin-származékok, intermedierjeik, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
ATE231918T1 (de) Verfahren zur fermentativen herstellung von l- cystein oder l-cystein-derivaten
NO971677D0 (no) Kondenserte pyrrolokarbazoler
DK0802188T3 (da) Heteroforbundne phenylglycinolamider som antiatherosklerotiske lægemidler
EA199800768A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
IL119321A0 (en) Substituted milbemycin 5-oxime derivatives and pesticidal compositions containing the same
TW258735B (pt)
IE901350L (en) Diaminoethylene compounds
HUP0003958A2 (hu) Eljárás 4-aril-piperidinek előállítására és az eljárásban alkalmazott intermedierek
ATE420869T1 (de) Promotoren zur proliferation und differenzierung von stammzellen und/oder vorstufen von neuronenzellen
DE69525763D1 (de) 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENE, DIE LDL OXIDATION HEMMEN
DE60032827D1 (de) Verfahren und Oxazolidin Zwischenprodukt zur Herstellung von Taxanen
ES2059595T3 (es) Beta-carbonil-carboxiamidas de 1,3-tiazolidinas.
ATE189203T1 (de) Trizyklische derivate, ihre herstellung, ihre verwendung zur herstellung von optisch aktivem oder racemischem colchizin, thiocolchizin, dessen analoge oder derivate, und intermediate
ATE328055T1 (de) Substituierte lineare thioureaverbindungen als schmiermittelzusatzstoff
ATE210675T1 (de) Zwischenprodukten für oligonukleotid-synthese
KR840005711A (ko) N-치환-n-사이클로펜틸 글리신 유도체의 제조방법
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ATE155785T1 (de) Mitomycinderivate
IL94898A (en) Preparation of s-2,2,r1. r2-1,3-dioxolane-4- methanols
ES529415A0 (es) Procedimiento para la preparacion de derivados de piridin-pirimidinona
TH22634A (th) " เบนซอกซาโซลิล และเบนโซไธอะโซลิลออกซาโซลิดิโนน "
TH18894A (th) วิธีสำหรับเตรียมกล้าเชื้อ va ไมคอไรซ่า

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A , 7A , 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1855 DE 25/07/2006.